Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1999
12/21/1999US6005010 Cardiovascular disorders, antiarrhythmia agents and antiischemic agents
12/21/1999US6004931 Method for inhibiting growth hormone action
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/21/1999US6004551 Lactobacillus, skim milk, lactobacillus growth factor (lgf) and lactobacillus compositions which adhere to biomaterials, intestinal, vaginal and uroepithelial cells, to resist the action of certain anti-microbial agents
12/21/1999CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/16/1999WO1999065228A2 Pharmaceutical combination used to compensate for a testosterone deficiency while protecting the prostate
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999WO1999064410A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
12/16/1999WO1999064409A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999050268A3 Substituted indolealkanoic acids
12/16/1999WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999DE19825804A1 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung 1,4-benzothiazepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/15/1999EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/15/1999CN1238773A Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
12/15/1999CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999CN1238201A Shenkangsan-medicine for treating nephrosis
12/14/1999US6001855 Thiazole derivatives
12/14/1999US6001830 Heterocyclic compounds
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999CA2155910C Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
12/14/1999CA2135487C Heteroaromatic quinuclidinenes, their use and preparation
12/09/1999WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999WO1999062902A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999WO1999062890A1 Isothiazole derivatives useful as anticancer agents
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999CA2333756A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/08/1999EP0962529A1 Synthesis of human procollagens and collagens in recombinant DNA systems
12/08/1999EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999EP0962225A2 Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/07/1999US5998579 Epimorphin antagonist and process for producing it
12/07/1999US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999US5998459 Incotinence therapy
12/07/1999US5998443 Phosphorous containing benzothiophenes for treating estrogen deficiency
12/07/1999US5998430 Bladder and urinary system disorders
12/07/1999US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/07/1999US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999US5998377 Administration of lh-rh antagonist cetrorelix in combination with at least one .alpha.-reductase inhibitor; without the side effects associated with testosterone levels being in a castration range.
12/07/1999CA2161103C Controlled release oxybutynin formulations
12/07/1999CA2020663C Substitution analogues of magainin peptides
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 562